US Bancorp
CDMO

US Bancorp’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

US Bancorp’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5
Closed -$36 – 4204
2024
Q2 		$36 Buy
+5
New +$38 ﹤0.01% 3945
2023
Q3 		– Sell
-89
Closed -$1.24K – 4136
2023
Q2 		$1.24K Sell
89
-5,942
-99% -$101K ﹤0.01% 3783
2023
Q1 		$113K Buy
6,031
+1,171
+24% +$19.2K ﹤0.01% 2130
2022
Q4 		$66.9K Buy
4,860
+1,033
+27% +$15.8K ﹤0.01% 2372
2022
Q3 		$73K Hold
3,827
– – ﹤0.01% 2333
2022
Q2 		$58K Buy
3,827
+80
+2% +$1.18K ﹤0.01% 2504
2022
Q1 		$76K Buy
+3,747
New +$76.3K ﹤0.01% 2408

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

US Bancorp's CDMO Position: Q3 2024 in Review

US Bancorp sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2024, closing a stake of 5 shares — an estimated $36 sold.

US Bancorp first reported a position in CDMO in Q1 2022 and held it in 7 quarters. The position peaked at $113K in Q1 2023. 171 funds tracked by Wall St. Rank hold CDMO as of Q3 2024.

  • US Bancorp reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • US Bancorp sold 5 Avid Bioservices, Inc. Common Stock shares in Q3 2024, an estimated $36.
  • US Bancorp first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
  • US Bancorp's Avid Bioservices, Inc. Common Stock position peaked at $113K in Q1 2023.
  • 171 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2024.

Based on US Bancorp's 13F filing for Q3 2024, filed 28 Oct 2024.